References:
Albanyan, S., Al Teneiji, A., Monfared, N., & Mercimek-Mahmutoglu, S. (2017). BCAP31-associated encephalopathy and complex movement disorder mimicking mitochondrial encephalopathy. Am J Med Genet A, 173 (6), 1640-1643. doi:10.1002/ajmg.a.38127
Allen, R. C., Zoghbi, H. Y., Moseley, A. B., Rosenblatt, H. M., & Belmont, J. W. (1992). Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. Am J Hum Genet, 51 (6), 1229-1239. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/1281384
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1682906/pdf/ajhg00070-0056.pdf
Amos-Landgraf, J. M., Cottle, A., Plenge, R. M., Friez, M., Schwartz, C. E., Longshore, J., & Willard, H. F. (2006). X chromosome-inactivation patterns of 1,005 phenotypically unaffected females. Am J Hum Genet, 79 (3), 493-499. doi:10.1086/507565
Annaert, W. G., Becker, B., Kistner, U., Reth, M., & Jahn, R. (1997). Export of cellubrevin from the endoplasmic reticulum is controlled by BAP31. J Cell Biol, 139 (6), 1397-1410. doi:10.1083/jcb.139.6.1397
Bertelsen, B., Tumer, Z., & Ravn, K. (2011). Three new loci for determining x chromosome inactivation patterns. J Mol Diagn, 13 (5), 537-540. doi:10.1016/j.jmoldx.2011.05.003
Cacciagli, P., Sutera-Sardo, J., Borges-Correia, A., Roux, J. C., Dorboz, I., Desvignes, J. P., . . . Villard, L. (2013). Mutations in BCAP31 cause a severe X-linked phenotype with deafness, dystonia, and central hypomyelination and disorganize the Golgi apparatus. Am J Hum Genet, 93 (3), 579-586. doi:10.1016/j.ajhg.2013.07.023
Calhoun, A. R., & Raymond, G. V. (2014). Distal Xq28 microdeletions: clarification of the spectrum of contiguous gene deletions involving ABCD1, BCAP31, and SLC6A8 with a new case and review of the literature.Am J Med Genet A, 164A (10), 2613-2617. doi:10.1002/ajmg.a.36661
Desmet, F. O., Hamroun, D., Lalande, M., Collod-Beroud, G., Claustres, M., & Beroud, C. (2009). Human Splicing Finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res, 37 (9), e67. doi:10.1093/nar/gkp215
Echevarria, L., Benistan, K., Toussaint, A., Dubourg, O., Hagege, A. A., Eladari, D., . . . Germain, D. P. (2016). X-chromosome inactivation in female patients with Fabry disease. Clin Genet, 89 (1), 44-54. doi:10.1111/cge.12613
Elstein, D., Schachamorov, E., Beeri, R., & Altarescu, G. (2012). X-inactivation in Fabry disease. Gene, 505 (2), 266-268. doi:10.1016/j.gene.2012.06.013
Fahim, A. T., Sullivan, L. S., Bowne, S. J., Webb-Jones, K., Wheaton, D. K. H., Branham, K. E., . . . Daiger, S. P. (2019). X-Chromosome Inactivation is a Biomarker of Clinical Severity in Female Carriers of X-linked Retinitis Pigmentosa. Investigative Ophthalmology & Visual Science, 60 (9). Retrieved from <Go to ISI>://WOS:000488628107093
Juchniewicz, P., Kloska, A., Tylki-Szymanska, A., Jakobkiewicz-Banecka, J., Wegrzyn, G., Moskot, M., . . . Piotrowska, E. (2018). Female Fabry disease patients and X-chromosome inactivation. Gene, 641 , 259-264. doi:10.1016/j.gene.2017.10.064
Li, Q., & Wang, K. (2017). InterVar: Clinical Interpretation of Genetic Variants by the 2015 ACMG-AMP Guidelines. American Journal of Human Genetics, 100 (2), 267-280. doi:10.1016/j.ajhg.2017.01.004
Minks, J., Robinson, W. P., & Brown, C. J. (2008). A skewed view of X chromosome inactivation. J Clin Invest, 118 (1), 20-23. doi:10.1172/JCI34470
Morrone, A., Cavicchi, C., Bardelli, T., Antuzzi, D., Parini, R., Di Rocco, M., . . . Zammarchi, E. (2003). Fabry disease: molecular studies in Italian patients and X inactivation analysis in manifesting carriers.J Med Genet, 40 (8), e103. doi:10.1136/jmg.40.8.e103
Nguyen, M., Breckenridge, D. G., Ducret, A., & Shore, G. C. (2000). Caspase-resistant BAP31 inhibits fas-mediated apoptotic membrane fragmentation and release of cytochrome c from mitochondria. Mol Cell Biol, 20 (18), 6731-6740. doi:10.1128/mcb.20.18.6731-6740.2000
Osaka, H., Takagi, A., Tsuyusaki, Y., Wada, T., Iai, M., Yamashita, S., . . . Matsumoto, N. (2012). Contiguous deletion of SLC6A8 and BAP31 in a patient with severe dystonia and sensorineural deafness. Mol Genet Metab, 106 (1), 43-47. doi:10.1016/j.ymgme.2012.02.018
Rinaldi, B., Van Hoof, E., Corveleyn, A., Van Cauter, A., & de Ravel, T. (2020). BCAP31-related syndrome: The first de novo report. Eur J Med Genet, 63 (2), 103732. doi:10.1016/j.ejmg.2019.103732
Shimizu, K., Oba, D., Nambu, R., Tanaka, M., Oguma, E., Murayama, K., . . . Ohashi, H. (2020). Possible mitochondrial dysfunction in a patient with deafness, dystonia, and cerebral hypomyelination (DDCH) due to BCAP31 Mutation. Mol Genet Genomic Med, 8 (3), e1129. doi:10.1002/mgg3.1129
Shvetsova, E., Sofronova, A., Monajemi, R., Gagalova, K., Draisma, H. H. M., White, S. J., . . . Consortium, G. (2019). Skewed X-inactivation is common in the general female population. European Journal of Human Genetics, 27 (3), 455-465. doi:10.1038/s41431-018-0291-3
van de Kamp, J. M., Errami, A., Howidi, M., Anselm, I., Winter, S., Phalin-Roque, J., . . . Salomons, G. S. (2015). Genotype-phenotype correlation of contiguous gene deletions of SLC6A8, BCAP31 and ABCD1.Clin Genet, 87 (2), 141-147. doi:10.1111/cge.12355
van den Berg, I. M., Laven, J. S. E., Stevens, M., Jonkers, I., Galjaard, R. J., Gribnau, J., & van Doorninck, J. H. (2009). X Chromosome Inactivation Is Initiated in Human Preimplantation Embryos.American Journal of Human Genetics, 84 (6), 771-779. doi:10.1016/j.ajhg.2009.05.003
Vittal, P., Hall, D. A., & Berry-Kravis, E. (2015). BCAP31 mutation causing congenital dystonia and central hypomyelination discovered using exome sequencing. Movement Disorders, 30 , S206-S207. Retrieved from <Go to ISI>://WOS:000356598200524
Vittal, P., Hall, D. A., Dames, S., Mao, R., & Berry-Kravis, E. (2016). BCAP31 Mutation Causing a Syndrome of Congenital Dystonia, Facial Dysorphism and Central Hypomyelination Discovered Using Exome Sequencing. Mov Disord Clin Pract, 3 (2), 197-199. doi:10.1002/mdc3.12250
Wakana, Y., Takai, S., Nakajima, K., Tani, K., Yamamoto, A., Watson, P., . . . Tagaya, M. (2008). Bap31 is an itinerant protein that moves between the peripheral endoplasmic reticulum (ER) and a juxtanuclear compartment related to ER-associated Degradation. Mol Biol Cell, 19 (5), 1825-1836. doi:10.1091/mbc.E07-08-0781
Whalen, S., Gomart, A., Mignot, C., De Villemeur, T. B., Gerasimenko, A., Heron, D., . . . Chantot-Bastaraud, S. (2019). Novel patient with Contiguous ABCD1/DXS1375E (BCAP31) Deletion Syndrome (CADDS) and review of the literature. European Journal of Human Genetics, 27 , 1497-1498. Retrieved from <Go to ISI>://WOS:000489313903213